Impact of different postoperative adjuvant therapies on the survival of early-stage cervical cancer patients with one intermediate-risk factor: A multicenter study of 14 years.
Yanna YeZhiqiang LiShan KangXuemei ZhanYi ZhangYan XuWeili LiJinghe LangChunlin ChenChunlin ChenPublished in: The journal of obstetrics and gynaecology research (2023)
Postoperative adjuvant radiotherapy, chemoradiotherapy, and chemotherapy are not associated with survival outcomes of ECC patients with one IPF. Considering the side effects and impact on patients' quality of life, the PATs should be carefully considered.
Keyphrases
- early stage
- locally advanced
- end stage renal disease
- patients undergoing
- ejection fraction
- newly diagnosed
- chronic kidney disease
- risk factors
- rectal cancer
- sentinel lymph node
- radiation therapy
- squamous cell carcinoma
- idiopathic pulmonary fibrosis
- radiation induced
- neoadjuvant chemotherapy
- patient reported outcomes
- free survival
- patient reported